Phase III POSEIDON Trial Shows Positive Results For Patients Taking…
“The POSEIDON trial showed that patients who received durvalumab and tremelimumab and chemotherapy experienced statistically significant and clinically meaningful improvements in both progression-free survival and overall survival compared to patients…